Label: information for the user
Xarelto 1mg/ml powder for oral suspension
rivaroxaban
Read this label carefully before starting to take this medication, as it contains important information. This label has been written for the patient (“you”) and for the parent or caregiver who will administer this medication to the child.
1.What is Xarelto and how is it used
2.What you need to know before starting to take or administer Xarelto
3.How to take or administer Xarelto
4.Possible adverse effects
5.Storage of Xarelto
6.Contents of the package and additional information
Xarelto contains the active ingredient rivaroxaban.
Xarelto belongs to a group of medications called antithrombotic agents. It acts by blocking a coagulation factor (factor Xa) and thereby reducing the tendency of blood to form clots.
Xarelto is used in term newborns, infants, children, and adolescents under 18 years old for:
Read and follow the Instructions for use provided with this medication, as they will show you how to prepare and take or administer Xarelto oral suspension.
Do not take or administer Xareltoif you or the childis allergic to rivaroxaban or any of the other components of this medication (listed in section6)
Do not take or administer Xarelto and inform your doctorif any of these circumstances apply to your case or the child.
Warnings and precautions
Consult your doctor or pharmacist before starting to use Xarelto if:
Inform your doctorif you or the child presents any of these situationsbefore taking or administering Xarelto.The doctor will decide if you or the child should be treated with this medication and be under closer observation.
Do not administerXarelto to children under 6months of age who
-have been born before 37 weeks of gestation, or
-weigh less than 2.6kg, or
-have taken breast milk or received formula feed for less than 10days
In these cases, the Xarelto dosage cannot be determined reliably and has not been studied in these children.
If you or the child needs a surgical intervention
Children and adolescents
Xarelto oral suspension should be used in patientsunder 18yearsto treat blood clots and prevent the recurrence of blood clots in the veins or pulmonary blood vessels. There is not enough information available on its use in children and adolescents for other indications.
Other medications and Xarelto
Inform your doctor or pharmacist if you or the child is taking, has taken recently, or may need to take any other medication, including those purchased without a prescription.
If any of the above circumstances apply to you or the child,inform your doctorbefore taking or administering Xarelto, as the effect of Xarelto may be increased.Your doctor will decide if you or the child should be treated with this medication and be under closer observation.
If the doctor considers that you or the child has a higher risk of developing a stomach or intestinal ulcer, a preventive treatment may be necessary.
If any of the above circumstances apply to you or the child,inform your doctorbefore taking or administering Xarelto, as the effect of Xarelto may be reduced. The doctor will decide if you or the child should be treated with this medication and be under closer observation.
Pregnancy and breastfeeding
Driving and using machines
Xarelto may cause dizziness or fainting. Neither you nor the child should drive, ride a bike, or use tools or machines if affected by these symptoms.
Xarelto contains sodium benzoate and sodium
This medication contains 1.8mg of sodium benzoate (E211) per ml of oral suspension. Sodium benzoate (E 211) may increase the risk of jaundice (yellowing of the skin and eyes) in newborns (up to 4weeks of age).
This medication contains less than 1 mmol of sodium (23mg) per milliliter; it is essentially “sodium-free”.
Follow exactly the administration instructions for this medication as indicated by your doctor for you or the child. In case of doubt, consult your doctor or pharmacist again.
Ensure that the correct information about how much and how often to take or administer Xarelto is written in the designated area of the box. If not, ask your pharmacist or doctor to provide the relevant information.
Instructions for use
To know how to prepare and take or administer the oral suspension of Xarelto:
How to take or administer
Take or administer Xarelto oral suspension with food (breast milk or formula) or with a meal. Each dose of Xarelto must be swallowed with a normal amount of liquid (for example, 20ml in children from 6months to 240ml in adolescents). This normal amount may include a usual amount of feeding liquid (for example, breast milk, infant formula, nutritional drink).
Your doctor may also administer the oral suspension through a tube inserted into the stomach.
How much to take or administer
The dose of Xarelto depends on the patient's body weight. The doctor will calculate it as an amount (volume) in milliliters (ml) of the oral suspension. This must be measured using the blue syringe (either the 1ml or 5ml or 10ml syringe, see table1) provided with this medication. Your doctor will prescribe the necessary volume including the specific syringe to use.
Your doctor will tell you how much of the oral suspension to take or administer.
Below is the table that your doctor will use.Do not adjust the dose on your own.
All materials for preparing and administering the oral suspension are provided with the medication (except for tap water). Use only still water to avoid bubbles.Use only the syringe providedto administer Xarelto to ensure exact dosing. Do not use any other method to administer the solution, such as an alternative syringe, spoon, etc.
Since the dose of Xarelto is based on body weight, it is essential to attend scheduled visits with the doctor, as the dose may need to be adjusted as the weight changes, especially in children under 12kg. This ensures that the child receives the correct dose of Xarelto.
Table1: Recommended dose of Xarelto in children
Individual dose* | Frequency of daily administration | Daily total dose* | Appropriate blue syringe | |
2.6 to less than 3 | 0.8ml | 3times | 2.4ml | 1ml |
3 to less than 4 | 0.9ml | 2.7ml | ||
4 to less than 5 | 1.4ml | 4.2ml | 5ml | |
5 to less than 7 | 1.6ml | 4.8ml | ||
7 to less than 8 | 1.8ml | 5.4ml | ||
8 to less than 9 | 2.4ml | 7.2ml | ||
9 to less than 10 | 2.8ml | 8.4ml | ||
10 to less than 12 | 3.0ml | 9.0ml | ||
12 to less than 30 | 5.0ml | 2times | 10.0ml | 5ml or 10ml |
30 to less than50 | 15.0ml | once | 15.0ml | 10ml |
50 or more | 20.0ml | 20.0ml | ||
*1ml of the oral suspension corresponds to 1mg of rivaroxaban. |
Your doctor may also prescribe tablets if you or the child are able to swallow the tablet and weigh at least 30kg.
When to take or administer Xarelto
Take or administer the oral suspension as instructed every day until your doctor tells you to stop.
Take or administer the oral suspension at the same time every day to help you remember. Consider setting an alarm to remind you.
Please observe the child to ensure they take the entire dose.
If your doctor has instructed you to take or administer the Xarelto dose:
-once a day, take it with approximately 24hours of difference
-twice a day, take it with approximately 12hours of difference
-three times a day, take it with approximately 8hours of difference
Your doctor will decide how long you or the child should continue treatment.
If you or the child spits out the dose or vomits
Call your doctor if you or the child repeatedly spits out the dose or vomits after taking Xarelto.
If you forgot to take or administer Xarelto
The next day after the missed dose, continue as prescribed by your doctor, one, two, or three times a day.
If you take or administer more Xarelto than you should
Call your doctor immediately if you have taken or administered too much Xarelto oral suspension. Taking too much Xarelto increases the risk of bleeding.
If you interrupt Xarelto treatment
Do not stop Xarelto treatment without consulting your doctor first, as Xarelto treats and prevents serious conditions.
If you have any other questions about using this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
Like other medicines similar to reduce blood clot formation, Xarelto may cause bleeding that can put the patient's life at risk. Excessive bleeding can cause a sudden drop in blood pressure (shock). In some cases, bleeding may not be apparent.
Inform your doctor immediatelyif you or the child experiences any of the following side effects:
Your doctor may decide to keep you or the child under closer observation or change the treatment.
The frequency of these side effects is very rare (up to 1 in 10,000 people).
The frequencies of severe allergic reactions are very rare (anaphylactic reactions, including anaphylactic shock; may affect up to 1 in 10,000 people) and uncommon (angioedema and allergic edema; may affect up to 1 in 100 people).
General list of possible side effects found in adults and children and adolescents:
Frequent(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
Rare(may affect up to 1 in 1,000 people)
Very rare(may affect up to 1 in 10,000 people)
Frequency unknown(frequency cannot be estimated from available data)
Side effects in children and adolescents
In general, the side effects observed in children and adolescents treated with Xarelto were similar to those observed in adults, and their severity was mainly mild to moderate.
Side effects that were observed more frequently in children and adolescents:
Very frequent(may affect more than 1 in 10 people)
Frequent(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
Reporting side effects
If you or the child experiences any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through thenational notification system included in theAppendix V.By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging and in the bottle after “CAD” or “EXP”.
The expiration date is the last day of the month indicated.
After preparation, the shelf life of the suspension is 14days at room temperature.
Do not store at a temperature above 30°C.
Do not freeze. Store the prepared suspension in an upright position.
Medications should not be disposed of through drains or in the trash. Ask your pharmacist how to dispose of the packaging and medications that you no longer need. By doing so, you will help protect the environment.
Composition of Xarelto
After preparation, each ml of the oral suspension contains 1 mg of rivaroxaban.
Appearance of the product and contents of the package
Xarelto granulated for oral suspension is a white granulated in a glass bottle with a child-resistant screw cap.
Package sizes
Foldable box with a brown glass bottle containing 2.625 g of granulate (equivalent to 51.7 mg of rivaroxaban), two blue syringes of 1 ml, a 50 ml water syringe and an adapter.
Foldable box with a brown glass bottle containing 5.25 g of granulate (equivalent to 103.4 mg of rivaroxaban), two blue syringes of 5 ml and two blue syringes of 10 ml, a 100 ml water syringe and an adapter.
Only some package sizes may be marketed.
The adjusted dose volume and frequency according to individual weight must be specified by the prescribing physician. They must be written on the outer box when provided to parents, caregivers or patients.
Follow the Instructions for Use leaflet supplied with each package.
Watch the educational video that can be accessed through the QR code on the patient information leaflet provided with the medication.
Holder of the marketing authorization and responsible for manufacturing
Bayer AG
51368 Leverkusen
Germany
For more information about this medicine, please contact the local representative of the marketing authorization holder:
België / Belgique / Belgien Bayer SA-NV Tél/Tel: +32-(0)2-535 63 11 | Lietuva UAB Bayer Tel: +370-5-233 68 68 |
Luxembourg / Luxemburg Bayer SA-NV Tél/Tel: +32-(0)2-535 63 11 | |
Ceská republika Bayer s.r.o. Tel: +420-2 66 101 111 | Magyarország Bayer Hungária KFT Tel: +36-1-487 4100 |
Danmark Bayer A/S Tlf: +45-45 235 000 | Malta Alfred Gera and Sons Ltd. Tel: +356-21 44 62 05 |
Deutschland Bayer Vital GmbH Tel: +49-(0)214-30 513 48 | Nederland Bayer B.V. Tel: +31–(0)297-28 06 66 |
Eesti Bayer OÜ Tel: +372-655 85 65 | Norge Bayer AS Tlf: +47-23 13 05 00 |
Ελλάδα Bayer Ελλάς ΑΒΕΕ Τηλ:+30-210-618 75 00 | Österreich Bayer Austria Ges. m. b. H. Tel: +43-(0)1-711 460 |
España Bayer Hispania S.L. Tel: +34-93-495 65 00 | Polska Bayer Sp. z o.o. Tel: +48-22-572 35 00 |
France Bayer HealthCare Tél (N° vert): +33-(0) 800 87 54 54 | Portugal Bayer Portugal, Lda. Tel: +351-21-416 42 00 |
Hrvatska Bayer d.o.o. Tel: + 385-(0)1-6599 900 | România SC Bayer SRL Tel: +40-(0)21-528 59 00 |
Ireland Bayer Limited Tel:+353 1 216 3300 | Slovenija Bayer d. o. o. Tel: +386-(0)1-58 14 400 |
Ísland Icepharma hf. Sími: +354-540 80 00 | Slovenská republika Bayer, spol. s r.o. Tel: +421-(0)2-59 21 31 11 |
Italia Bayer S.p.A. Tel: +39-02-3978 1 | Suomi/Finland Bayer Oy Puh/Tel: +358-(0)20-78521 |
Κύπρος NOVAGEM Limited Τηλ: +357-22-48 38 58 | Sverige Bayer AB Tel: +46-(0)8-580 223 00 |
Latvija SIA Bayer Tel: +371-67 84 55 63 | United Kingdom Bayer plc Tel: +44-(0)118 206 3000 |
Last update of this leaflet:
The detailed information on this medicine is available on the website of the European Medicines Agencyhttp://www.ema.europa.eu.
Instructions for Use (IU)
Instructions for Use
Xarelto 1 mg/ml
Package of 100 ml with 2.625 g of granulate for the preparation of an oral suspension
Active pharmaceutical ingredient: rivaroxaban
Preparation and administration of the oral suspension (granulate and water mixture)
Glossary and symbols
Before starting
Contents of the package
Each package of Xarelto contains the following components:
1bottle with a child-resistant screw capcontaining the Xarelto granulate | |
1water syringe of 50 ml pre-filled(for single use) | |
1adapter for pre-filled bottle | |
2blue syringes of 1 ml pre-filled | |
1copy of the Instructions for Use (IU)(this document) | |
1leaflet Provides important information about Xarelto. | |
1patient information leaflet Important information in case of emergency. The patient must carry it at all times and present it to each doctor or dentist before treatment. |
Warnings and precautions
Use of Xarelto
If not written on the designated field, ask your child's doctor or pharmacist to provide the relevant information.
Be careful to comply with the instructions related to administration:
1. Preparation of the oral suspension
Paso1.1: Preparation – Ready to go
The suspension preparation is done once with each new package.
Before preparing the suspension:
a. Wash hands thoroughly with soap and dry them afterwards. | |
b. Check the expiration date on the package label. Do notuse the medicine if it has already expired. | |
c. Obtain the following additional items:
| |
|
Paso1.2: Filling the required water volume
Each time a new package is started, only the new materials included in the new package should be used.
To do this, pull the plunger towards you and make sure the opening of the water syringe remains below the water surface at all times. This will prevent air bubbles in the syringe.
Small air bubbles are not critical, but large ones are critical. For more information on what to do, see below.
|
Paso1.3: Adding water to the granulate
| |
| |
| |
The entire water volume must be transferred to the bottle.
|
Paso1.4: Placing the adapter and mixing the oral suspension
The adapter is used to fill the blue syringe with the suspension.
a. Unpack the adapter from the bottle. | |
b. Push the adapter completely into the neck of the bottle. | |
c. Close the bottle tightly with the child-resistant screw cap. | |
d. Shake the bottlegentlyforat least 60 secondsseconds.
| |
e. Check that the suspension is well mixed:
| |
f.If there are lumps or sediment: Repeat steps d to f. | |
g. Write the expiration date of the freshly prepared suspension on the label of the bottle. Preparation date+14 days The pictogram shown is only an example. |
2. Adjusting the prescribed dose with each new blue syringe
To avoid overdosing or underdosing, an exact dose of suspension is required.
Before taking the first dose from the bottle, the blue syringe provided must be prepared according to the prescribed dose by your child's doctor. This information can be found in the designated area of the package. If no information has been entered here, consult with your child's doctor or pharmacist.
After setting the dose, the same blue syringe can be used for all administrations to be made from the prepared suspension bottle in step1.
Once the dose has been set in the blue syringe, it cannot be changed.
Paso2.1: Selecting a suitable blue syringe
In this package, devices of different capacities are included:
blue syringes of 5 mlfor doses of1mlto5ml | ||
blue syringes of 10 mlfor doses of5mlto10ml | ||
The other blue syringes are not necessary.
Nota: Do not remove the removable label until instructed to do so in the Instructions for Use. The blue syringe has a red button for adjusting the volume. This button is initially covered by a removable label. The volume of the syringe is set by pressing the red button, which can only be done once.Do notpress the red button until instructed to do so in the Instructions for Use. Once the red button has been pressed, the volume cannot be adjusted. | ||
Paso2.2: Adjusting the required dose in the new blue syringe The blue syringe has a scale (ml). The scale of the 5 ml blue syringe starts at 1 ml. The graduation marks are in increments of 0.2 ml. The scale of the 10 ml blue syringe starts at 2 ml. The graduation marks are in increments of 0.5 ml. | ||
Nota: Use the 10 ml blue syringe for prescribed doses above 10 ml in the following way: Dose of 15 ml: 2 x 7.5 ml from the blue syringe Dose of 20 ml: 2 x 10 ml from the blue syringe | ||
Ask your pharmacist or doctor to provide it. | ||
c. Hold the blue syringe with the opening facing upwards. | ||
d. Pull the plunger slowly until the upper ring reaches the mark of the volume to be administered.
The pictogram shown is only an example. Your volume may be different. Be careful, do notpull the plunger beyond the volume to be administered. Be careful, do notpress the label when pulling the plunger. | ||
e. Completely remove the removable label from the blue syringe.
f. Check the position of the plunger again. Make sure the upper edge of the plunger is exactly aligned with the correct mark of the volume to be administered. g.If the position of the blue plunger does not match the required volume: Adjust it accordingly. | ||
h. If the position of the blue plunger matches the required volume, press the red button to set the adjustment.
The clicking sound will not be audible afterwards. | ||
i. Push the plunger up in the blue syringe until it reaches the top. The blue syringe is now ready to use. |
Follow the steps described below for each necessary administration.
Paso3.1: Mixing the oral suspension
a.Shakegentlythe bottle forat least 10 secondssecondsbeforeeach dose.
| |
b. Check that the suspension is well mixed, i.e.:
| |
c.If there are lumps or deposits: Repeat steps a and b. | |
d. The agitation may cause foam to form. Leave the bottle to rest until the foam dissolves. | |
e. Remove the child-resistant screw cap from the bottle, but keep the adapter on the top of the bottle. Nota: The largest visible opening in the adapter is used to connect the blue syringe. The surface of the adapter on the bottle must be free of liquid. f.If there is liquid in the adapter: Remove the liquid with a clean paper towel. |
Paso3.2: Extracting the required dose
|